Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma.

Blood
Craig S SauterCraig H Moskowitz

Abstract

High-dose chemotherapy (HDT) plus autologous stem cell transplantation (ASCT) is the standard of care for chemosensitive relapsed and refractory diffuse large B-cell lymphoma (rel/ref DLBCL). Interim restaging with functional imaging by positron emission tomography using (18)F-deoxyglucose (FDG-PET) has not been established after salvage chemotherapy (ST) and before HDT-ASCT by modern criteria. Herein, we evaluated 129 patients with rel/ref DLBCL proceeding to HDT-ASCT, with ST response assessment by FDG-PET according to the contemporary Deauville 5-point scale. At 3 years, patients achieving a Deauville response of 1 to 3 to ST experienced superior progression-free survival (PFS) and overall survival (OS) rates of 77% and 86%, respectively, compared with patients achieving Deauville 4 (49% and 54%, respectively) (P < .001). No other pre-HDT-ASCT risk factors significantly impacted PFS or OS. Despite achieving remission to ST, patients with Deauville 4 should be the focus of risk-adapted investigational therapies.

References

Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B D ChesonG P Canellos
Mar 12, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bradford S HoppeJoachim Yahalom
Jun 23, 2009·Leukemia & Lymphoma·Michel MeignanCorinne Haioun
Jul 5, 2011·The Journal of Arthroplasty·John W Barrington, Thomas A Barrington
Oct 24, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christian GisselbrechtBertram Glass
Feb 13, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Diego VillaJohn Kuruvilla
Feb 19, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Craig S SauterCraig H Moskowitz

❮ Previous
Next ❯

Citations

Feb 24, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Miguel-Angel PeralesPhilippe Armand
Oct 21, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Miguel-Angel PeralesPhilippe Armand
Apr 6, 2016·Clinical Radiology·A F Scarsbrook, S F Barrington
Apr 21, 2016·Current Hematologic Malignancy Reports·Sally F Barrington, N George Mikhaeel
May 20, 2016·British Journal of Haematology·Sridhar ChagantiUNKNOWN British Committee for Standards in Haematology
Jul 23, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ryan D CassadayAjay K Gopal
Aug 3, 2016·The Journal of Clinical Investigation·Partow KebriaeiLaurence J N Cooper
Dec 18, 2016·Journal of the National Cancer Institute·Grzegorz S NowakowskiSonali M Smith
Dec 13, 2016·European Journal of Haematology·Hugo J A Adams, Thomas C Kwee
Jun 14, 2017·Nature Reviews. Clinical Oncology·Joel CunninghamBhupinder Sharma
May 4, 2018·Hematological Oncology·Lauriane Filliatre-ClementClémentine Sarkozy
Oct 30, 2016·Expert Review of Hematology·Vincent Camus, Hervé Tilly
May 29, 2018·British Journal of Haematology·Christian Gisselbrecht, Eric Van Den Neste
Jul 11, 2018·Journal of Internal Medicine·T C El-GalalyC Y Cheah
Nov 22, 2019·Leukemia & Lymphoma·Kirk E CahillPeter A Riedell
May 19, 2020·American Society of Clinical Oncology Educational Book·Jeremy S AbramsonSonali M Smith
Apr 16, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Sally F Barrington, Regine Kluge
Apr 21, 2018·Blood·Sarit Assouline
Jan 18, 2017·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Hina J ShahPamela J DiPiro
Dec 15, 2018·British Journal of Haematology·Alba M RedondoUNKNOWN Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea (GELTAMO)
Dec 4, 2016·Hematology·Bertrand Coiffier, Clémentine Sarkozy
Dec 29, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gustaaf W van ImhoffAnton Hagenbeek
Jan 13, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alvaro J Alencar, Craig H Moskowitz
Sep 20, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Susan BalMehdi Hamadani
Nov 2, 2019·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Malvi SavaniVeronika Bachanova
Jun 5, 2020·The Cancer Journal·Brandon S Imber, Joachim Yahalom
Feb 4, 2021·Seminars in Nuclear Medicine·Heather A Jacene

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.